Asma Khan

The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease

D. L. Price, Maya A. Koike, Asma Khan et al. · Scientific Reports · 2018 · 160 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Latency as a function of intensity in auditory neurons: influences of central processing

A. Klug, Asma Khan, R. Michael Burger et al. · Hearing Research · 2000 · 80 citations

Life Sciences, Neurobiology, Neuroscience +14

Simultaneous monitoring of potassium, glucose and lactate during spreading depolarization in the injured human brain – Proof of principle of a novel real-time neurochemical analysis system, continuous online microdialysis

Michelle L. Rogers, Chi Leng Leong, Sally A. N. Gowers et al. · Journal of Cerebral Blood Flow & Metabolism · 2016 · 73 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15

In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease

D. L. Price, Asma Khan, Rachel Angers et al. · npj Parkinson s Disease · 2023 · 33 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats

Susan B. Powell, Asma Khan, Jared W. Young et al. · Developmental Neuroscience · 2015 · 28 citations

Medicine, Behavioral Sciences, Neuroscience +17